APA (7th ed.) Citation

Zhuang, S., Sun, N., Qu, J., Chen, Q., Han, C., Yin, H., . . . Zhang, M. (2025). High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4+ T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response. Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism, 68(5), 1044-1056. https://doi.org/10.1007/s00125-024-06354-7

Chicago Style (17th ed.) Citation

Zhuang, Shaoyong, Nan Sun, Junwen Qu, Qian Chen, Conghui Han, Hao Yin, Xiaodong Yuan, and Ming Zhang. "High Glucose/ChREBP-induced Hif-1α Transcriptional Activation in CD4+ T Cells Reduces the Risk of Diabetic Kidney Disease by Inhibiting the Th1 Response." Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism 68, no. 5 (2025): 1044-1056. https://doi.org/10.1007/s00125-024-06354-7.

MLA (9th ed.) Citation

Zhuang, Shaoyong, et al. "High Glucose/ChREBP-induced Hif-1α Transcriptional Activation in CD4+ T Cells Reduces the Risk of Diabetic Kidney Disease by Inhibiting the Th1 Response." Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism, vol. 68, no. 5, 2025, pp. 1044-1056, https://doi.org/10.1007/s00125-024-06354-7.